about
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosisAbnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitisInteraction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitisSynaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosisA novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum.Cladribine interferes with IL-1β synaptic effects in experimental multiple sclerosis.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Interferon-γ causes mood abnormalities by altering cannabinoid CB1 receptor function in the mouse striatum.Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.TNF-α-mediated anxiety in a mouse model of multiple sclerosis.Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis.Tumor Necrosis Factor and Interleukin-1β Modulate Synaptic Plasticity during Neuroinflammation.Interplay Between Age and Neuroinflammation in Multiple Sclerosis: Effects on Motor and Cognitive FunctionsPre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitisGlatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune EncephalomyelitisTransient receptor potential vanilloid 1 channels modulate the synaptic effects of TNF-α and of IL-1β in experimental autoimmune encephalomyelitis
P50
Q35777988-42495FD5-D55F-4587-A5A7-D213DB9EDC8EQ36610373-8CC38BCB-803F-4E79-AA6F-A16F954C2D95Q37228420-9419FA1A-B68D-4215-A2A5-A0896C3FA7FAQ38639337-B05BD406-6BE2-4B3D-B796-A02D1112FD4CQ39448667-5FA55C86-452F-4977-A369-4329E34DD059Q41260178-DB73615B-340B-436A-9325-EC24C5F77E13Q46437031-AC8DE67F-AC2D-4631-918D-2340A510C34AQ47211013-5EF008CC-A69E-4B4A-BB4A-F7475D045F53Q47812042-10DEF17A-4960-447F-A2F1-99F505F73FBBQ47987358-A109519D-D09E-47EE-BF6B-CCF5539094DFQ48151704-558424B1-9D4B-45CD-BE21-823C02AF9D6DQ48338335-DFDF6DB5-06BF-46B0-B912-A5047894B08FQ48427603-F258803B-2EA5-4ADD-8BAB-CC765295A4C2Q52588409-98F45E16-2A36-4223-8EA1-69526C1DD6FEQ55115006-F665D6B3-8CCD-4E1E-9C98-8FF5700935CAQ58795499-0A88172D-AF9A-4BE3-AA18-CC84CD22E6D9Q60535497-6A3A332A-9449-49DF-9985-0ABC756C3E39Q60535501-173F52CE-9BB6-4F73-BB8B-BDFCB1812BE7Q60535512-F306058B-6033-4EB3-A19D-95BC490F87A6
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-6943-1904
@en
name
Diego Fresegna
@ast
Diego Fresegna
@en
Diego Fresegna
@es
Diego Fresegna
@nl
type
label
Diego Fresegna
@ast
Diego Fresegna
@en
Diego Fresegna
@es
Diego Fresegna
@nl
prefLabel
Diego Fresegna
@ast
Diego Fresegna
@en
Diego Fresegna
@es
Diego Fresegna
@nl
P106
P1153
40461316400
P21
P31
P496
0000-0002-6943-1904